Health Secretary Robert F. Kennedy Jr. announced extensive cutbacks at the F.D.A., potentially reducing its workforce by 20%. This move aims to streamline operations but has raised concerns from former staff about the dismantling of vital roles. Experts responsible for drug approvals, lab safety, and monitoring false claims in advertising are among those being laid off. These cuts threaten crucial functions, including payroll and oversight duties, which could jeopardize public health and safety. The former F.D.A. workforce believes these layoffs could leave significant regulatory gaps, reflecting a broader trend of underfunding in public health.
Health Secretary Robert F. Kennedy Jr. announced significant cutbacks at federal health agencies, including a 20 percent reduction in the F.D.A.'s workforce, aiming to eliminate duplicative services but facing backlash.
Interviews with former F.D.A. staff revealed layoffs leading to critical gaps in regulatory and safety processes, raising alarms over the potential impact on public health.
Collection
[
|
...
]